Security key
Y95308105
Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE)
CUSIP: Y95308105
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Ordinary Shares, no par value
- Shares outstanding
- 188,679,245
- Total 13F shares
- 138,939,054
- Share change
- +7,827,617
- Total reported value
- $903,136,388
- Put/Call ratio
- 7.3%
- Price per share
- $6.50
- Number of holders
- 174
- Value change
- +$46,387,682
- Number of buys
- 106
- Number of sells
- 77
Report period
Q2 2025
Institutions
174
Top holders
10
WVE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Wave Life Sciences Ltd. SEC filings
Wave Life Sciences Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP Y95308105
Recent filing periods:
Ownership snapshot
Top shareholders of WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
BlackRock, Inc.
13D/G signal
BlackRock, Inc.
Evidence rows
50
Latest as of
31 Mar 2025
13F
13D/G
Lead comparable stake: 6.1%
13D/G row: BlackRock, Inc.
Showing first 8 of 50 holder rows.
Open remaining rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
Company
|
6.1%
from 13D/G
|
$77,799,187
9,628,612 shares
|
— | 31 Mar 2025 |
| MAVERICK CAPITAL LTD |
13F
13D/G
Company
|
5.4%
from 13D/G
|
$66,754,399
8,261,683 shares
|
— | 31 Mar 2025 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
9.6%
|
$147,072,233
18,202,009 shares
|
— | 31 Mar 2025 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
6.6%
|
$101,133,320
12,516,500 shares
|
— | 31 Mar 2025 |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
Company
|
3.4%
|
$51,377,480
6,358,599 shares
|
— | 31 Mar 2025 |
| M28 Capital Management LP |
13F
Company
|
3%
|
$45,769,548
5,664,548 shares
|
— | 31 Mar 2025 |
| Kynam Capital Management, LP |
13F
Company
|
2.6%
|
$39,587,936
4,899,497 shares
|
— | 31 Mar 2025 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
2.2%
|
$33,333,000
4,125,291 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
174
Shares
138,939,054
Rows loaded
174
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
192
Q2 2025 holders
174
Holder diff
-18
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend